Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin...
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma
About this item
Full title
Author / Creator
Singh, Harshabad , Lowder, Kristen E. , Kapner, Kevin , Kelly, Ronan J. , Zheng, Hui , McCleary, Nadine Jackson , Abrams, Thomas A. , Chan, Jennifer A. , Regan, Eileen M. , Klempner, Samuel J. , Hannigan, Alison M. , Remland, Joshua , Brais, Lauren K. , Andrews, Elizabeth , Yurgelun, Matthew , Cleary, James M. , Rubinson, Douglas A. , Ritterhouse, Lauren L. , Maron, Garrett , Aguirre, Andrew J. , Meyerhardt, Jeffrey A. , Gardecki, Emma , Lennerz, Jochen K. , Wolpin, Brian M. and Enzinger, Peter C.
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Preclinical studies suggest that simultaneous HER2/VEGF blockade may have cooperative effects in gastroesophageal adenocarcinomas. In a single-arm investigator initiated clinical trial for patients with untreated advanced HER2+ gastroesophageal adenocarcinoma, bevacizumab was added to standard of care capecitabine, oxaliplatin, and trastuzumab in 3...
Alternative Titles
Full title
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma
Authors, Artists and Contributors
Author / Creator
Lowder, Kristen E.
Kapner, Kevin
Kelly, Ronan J.
Zheng, Hui
McCleary, Nadine Jackson
Abrams, Thomas A.
Chan, Jennifer A.
Regan, Eileen M.
Klempner, Samuel J.
Hannigan, Alison M.
Remland, Joshua
Brais, Lauren K.
Andrews, Elizabeth
Yurgelun, Matthew
Cleary, James M.
Rubinson, Douglas A.
Ritterhouse, Lauren L.
Maron, Garrett
Aguirre, Andrew J.
Meyerhardt, Jeffrey A.
Gardecki, Emma
Lennerz, Jochen K.
Wolpin, Brian M.
Enzinger, Peter C.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_df43da4c105c4a28ae7e276e1e916753
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_df43da4c105c4a28ae7e276e1e916753
Other Identifiers
ISSN
2041-1723
E-ISSN
2041-1723
DOI
10.1038/s41467-024-51271-3